Level Biotechnology Inc. - Laporan Laba Rugi (TTM)

Level Biotechnology Inc.
TW ˙ TPEX
NT$ 32.05 0.00 (0.00%)
2024-10-25
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Level Biotechnology Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 648 672 701 716 728 677 632 601 569 593 620 633 654 661 695 697 716 731 730 735
Change (%) 3.74 4.18 2.25 1.67 -7.01 -6.70 -4.86 -5.35 4.21 4.62 1.96 3.44 0.96 5.17 0.34 2.72 2.13 -0.19 0.74
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 448 461 476 487 491 445 411 385 365 390 411 424 442 441 466 469 481 494 498 496
Change (%) 2.96 3.20 2.32 0.90 -9.41 -7.65 -6.38 -5.10 6.98 5.32 3.01 4.41 -0.27 5.56 0.67 2.64 2.72 0.66 -0.38
% of Revenue 69.03 68.52 67.87 67.92 67.41 65.67 65.00 63.96 64.13 65.84 66.28 66.96 67.59 66.77 67.01 67.24 67.19 67.58 68.15 67.40
Gross Operating Profit 201 212 225 230 237 233 221 217 204 203 209 209 212 220 229 228 235 237 232 240
Change (%) 5.46 6.32 2.09 3.30 -2.05 -4.89 -2.03 -5.80 -0.73 3.27 -0.10 1.46 3.53 4.40 -0.34 2.87 0.92 -1.96 3.13
% of Revenue 30.97 31.48 32.13 32.08 32.59 34.33 35.00 36.04 35.87 34.16 33.72 33.04 32.41 33.23 32.99 32.76 32.81 32.42 31.85 32.60
SG&A 129 132 133 135 138 139 136 130 127 124 126 130 132 138 141 144 148 149 153 156
Change (%) 2.14 0.46 2.08 1.50 0.73 -1.74 -4.19 -2.25 -3.00 2.28 2.64 1.84 4.55 2.02 2.38 2.42 0.67 2.70 2.26
% of Revenue 19.95 19.64 18.94 18.91 18.88 20.45 21.54 21.69 22.40 20.85 20.39 20.52 20.20 20.92 20.30 20.71 20.65 20.35 20.94 21.26
R&D 14 14 14 14 15 15 15 15 14 14 14 14 14 14 13 13 13 13 13 13
Change (%) 1.25 1.34 2.94 1.62 3.46 -1.01 -2.35 -1.78 -1.61 0.63 1.20 -0.42 -3.24 -3.33 -2.13 -0.64 0.05 1.72 1.05
% of Revenue 2.09 2.04 1.98 1.99 1.99 2.22 2.35 2.42 2.51 2.37 2.28 2.26 2.17 2.08 1.92 1.87 1.81 1.77 1.80 1.81
OpEx 590 607 622 636 643 598 562 529 507 528 552 568 589 593 620 626 642 656 664 665
Change (%) 2.74 2.57 2.28 1.05 -6.95 -6.11 -5.74 -4.30 4.23 4.49 2.88 3.70 0.74 4.53 1.00 2.52 2.20 1.15 0.26
% of Revenue 91.07 90.20 88.80 88.83 88.28 88.34 88.90 88.07 89.04 89.06 88.94 89.74 89.97 89.77 89.22 89.81 89.65 89.70 90.90 90.46
Operating Income 58 66 78 80 85 79 70 72 62 65 69 65 66 68 75 71 74 75 66 70
Change (%) 13.86 19.08 1.97 6.63 -7.47 -11.15 2.22 -13.06 4.10 5.71 -5.42 1.13 2.93 10.83 -5.15 4.42 1.58 -11.79 5.55
% of Revenue 8.93 9.80 11.20 11.17 11.72 11.66 11.10 11.93 10.96 10.94 11.06 10.26 10.03 10.23 10.78 10.19 10.35 10.30 9.10 9.54
Interest Expense -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0
Change (%) -1.59 -1.84 -2.82 -4.59 -4.30 -3.70 -2.47 -0.56 -1.42 -1.44 -3.79 -2.73 3.43 -2.71 -0.31 -3.42 -9.97 -5.71 -6.82
% of Revenue -0.07 -0.06 -0.06 -0.06 -0.05 -0.06 -0.06 -0.06 -0.06 -0.06 -0.06 -0.05 -0.05 -0.05 -0.05 -0.05 -0.04 -0.04 -0.04 -0.03
Net Income 50 58 69 70 74 68 61 62 57 58 64 62 60 63 66 62 65 65 65 69
Change (%) 15.45 18.18 1.59 5.91 -7.61 -10.87 1.97 -8.18 2.76 9.28 -2.88 -3.20 4.72 4.38 -5.72 5.73 -0.98 1.05 5.20
% of Revenue 7.75 8.63 9.79 9.73 10.13 10.07 9.62 10.31 10.00 9.86 10.30 9.81 9.18 9.52 9.45 8.88 9.14 8.86 8.97 9.37

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista